INFU InfuSystem Holdings Forecast, Technical & Fundamental Analysis
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers... Show more
INFU is expected to report earnings to rise 165.00% to 13 cents per share on November 10
Q3'26
Est.
$0.13
Q1'26
Beat
by $0.02
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.06
The last earnings report on May 07 showed earnings per share of 5 cents, beating the estimate of 2 cents. With 199.53K shares outstanding, the current market capitalization sits at 248.77M.
A.I. Advisor
published General Information
General Information
a manufacturer of external ambulatory infusion pumps
A.I.dvisor indicates that over the last year, INFU has been loosely correlated with VREX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then VREX could also see price increases.
INFU's RSI Indicator is sitting in overbought zone for 3 days
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INFU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
INFU broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for INFU entered a downward trend on July 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on INFU as a result. In of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for INFU just turned positive on July 28, 2026. Looking at past instances where INFU's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .
INFU moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for INFU crossed bullishly above the 50-day moving average on August 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The 50-day moving average for INFU moved above the 200-day moving average on July 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where INFU advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INFU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.205) is normal, around the industry mean (10.714). P/E Ratio (31.225) is within average values for comparable stocks, (68.853). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.950). INFU has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (1.822) is also within normal values, averaging (36.904).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INFU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
